Home

Ensuring ACCESS TO SAFE AND EFFECTIVE MEDICINES FOR ALL is a complex challenge that requires innovation and collaboration.

Graphic illustration showing two biomedical scientists or doctors on one side of a large circle that is the CBI logo with many different people of the healthcare industry layered on it, from these two people a multi-colored arrow line goes across the circle with the worlds "healthcare value chain" and ends on the other side of the circle where a medicine vial and several people of different ethnicities and genders are together. Under it all is a map of the world.

Ensuring ACCESS TO SAFE AND EFFECTIVE MEDICINES FOR ALL is a complex challenge that requires innovation and collaboration.

Graphic illustration showing two biomedical scientists or doctors on one side of a large circle that is the CBI logo with many different people of the healthcare industry layered on it, from these two people a multi-colored arrow line goes across the circle with the worlds "healthcare value chain" and ends on the other side of the circle where a medicine vial and several people of different ethnicities and genders are together. Under it all is a map of the world.

Ensuring ACCESS TO SAFE AND EFFECTIVE MEDICINES FOR ALL is a complex challenge that requires innovation and collaboration.

Graphic illustration showing two biomedical scientists or doctors on one side of a large circle that is the CBI logo with many different people of the healthcare industry layered on it, from these two people a multi-colored arrow line goes across the circle with the worlds "healthcare value chain" and ends on the other side of the circle where a medicine vial and several people of different ethnicities and genders are together. Under it all is a map of the world.

MIT CBI is a COLLABORATION ENGINE that brings together the excellence of MIT researchers with stakeholders across the healthcare value chain.

Graphic illustration showing two biomedical scientists or doctors on one side of a large circle that is the CBI logo with many different people of the healthcare industry layered on it, from these two people a multi-colored arrow line goes across the circle with the worlds "healthcare value chain" and ends on the other side of the circle where a medicine vial and several people of different ethnicities and genders are together. Under it all is a map of the world.

MIT CBI is a COLLABORATION ENGINE that brings together the excellence of MIT researchers with stakeholders across the healthcare value chain.

Graphic illustration showing two biomedical scientists or doctors on one side of a large circle that is the CBI logo with many different people of the healthcare industry layered on it, from these two people a multi-colored arrow line goes across the circle with the worlds "healthcare value chain" and ends on the other side of the circle where a medicine vial and several people of different ethnicities and genders are together. Under it all is a map of the world.

MIT CBI is a COLLABORATION ENGINE that brings together the excellence of MIT researchers with stakeholders across the healthcare value chain.

Graphic illustration showing two biomedical scientists or doctors on one side of a large circle that is the CBI logo with many different people of the healthcare industry layered on it, from these two people a multi-colored arrow line goes across the circle with the worlds "healthcare value chain" and ends on the other side of the circle where a medicine vial and several people of different ethnicities and genders are together. Under it all is a map of the world.

Collaboratively, MIT CBI DESIGNS, TESTS, and IMPLEMENTS ways to ensure global access to safe and effective medicines.

Graphic illustration showing two biomedical scientists or doctors on one side of a large circle that is the CBI logo with many different people of the healthcare industry layered on it, from these two people a multi-colored arrow line goes across the circle with the worlds "healthcare value chain" and ends on the other side of the circle where a medicine vial and several people of different ethnicities and genders are together. Under it all is a map of the world.

Collaboratively, MIT CBI DESIGNS, TESTS, and IMPLEMENTS ways to ensure global access to safe and effective medicines.

Graphic illustration showing two biomedical scientists or doctors on one side of a large circle that is the CBI logo with many different people of the healthcare industry layered on it, from these two people a multi-colored arrow line goes across the circle with the worlds "healthcare value chain" and ends on the other side of the circle where a medicine vial and several people of different ethnicities and genders are together. Under it all is a map of the world.

Collaboratively, MIT CBI DESIGNS, TESTS, and IMPLEMENTS ways to ensure global access to safe and effective medicines.

Graphic illustration showing two biomedical scientists or doctors on one side of a large circle that is the CBI logo with many different people of the healthcare industry layered on it, from these two people a multi-colored arrow line goes across the circle with the worlds "healthcare value chain" and ends on the other side of the circle where a medicine vial and several people of different ethnicities and genders are together. Under it all is a map of the world.
previous arrow
next arrow
Slider

CBI provides integrated solutions to global health

Learn About Us

CBI Programs

Biomanufacturing@MIT-CBI focuses on technology, training, and knowledge networks in biomanufacturing to advance the safe, timely, and efficient production and delivery of biologic medicines.

MIT NEWDIGS is a global multi-stakeholder “think and do” tank focused on re-engineering drug therapy development, access, and use to be more patient-centered and economically sustainable.

Upcoming Events

Biomanufacturing@MIT-CBI


No event found!

NEWDIGS


No event found!

Latest News & Research

BioACCESS contributes to the IAVI Wellcome report on expanding global access to mAb-based products.

BioACCESS contributes to the IAVI Wellcome report on expanding global access to mAb-based products.

BioACCESS took part in consultations and reviewed the IAVI Welcome report, which sets out a roadmap to make lifesaving antibody…
NEWDIGS offers comment on CMS Proposed Rule supporting Value-Based Purchasing, July 20th, 2020

NEWDIGS offers comment on CMS Proposed Rule supporting Value-Based Purchasing, July 20th, 2020

On behalf of the NEWDIGS initiative / FoCUS Project, team members submitted comments on the recent CMS Proposed Rule supporting Value-Based Purchasing (VBP)…
Nature Biotechnology publishes CAACB Article on Viral Contamination in Biologic Manufacture and Implications for Emerging Therapies

Nature Biotechnology publishes CAACB Article on Viral Contamination in Biologic Manufacture and Implications for Emerging Therapies

This report, made possible through the efforts of our consortium members, offers lessons learned to help prevent viruses from contaminating…

Our Team

CBI’s core strength is in our team’s cross-cutting experience and expertise in medicine, biology, chemistry, biomanufacturing, academic & clinical research, economics, engineering, data analytics, regulatory science and public policy.

Our Members

Our members and collaborators are leading stakeholders across the global healthcare value chain, from R&D and manufacturing to delivery and reimbursement.

One Review on Home

    Slider shortcode: [smartslider3 slider="14"]

Comments are closed.